FDA Device Intelligence
HomeDRG International Inc › Prolactin ELISA

Prolactin ELISA

DRG International Inc · Model EIA-1291 · UDI-DI 00840239012913

CFT Prescription
10
510(k) clearances
244
Adverse events
6
Recalls
53
Facilities

Description

The DRG Prolactin ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of Prolactin in serum.

Recalls

DateFirmReason
2022-03-25Ortho-Clinical Diagnostics, IncFalsely high or delayed patient and QC results may occur due to low end imprecision. VITROS Immunodiagnostic Products FSH, LH and Prol Reagents Low End Imprecision. Low-level quali
2018-07-12Ortho Clinical Diagnostics IncThe recalling firm determined that biased results may occur for specific VITROS Immunodiagnostic Products (MicroWell Assays) at biotin concentrations which are lower than indicated
2018-03-05Tosoh Bioscience IncAsfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
2017-03-21Siemens Healthcare Diagnostics, Inc.The concentrations for Biotin listed in the Non-Interfering Substances section of the current Dimension and Dimension Vistat Instructions for Use (IFU) for Dimension TNI, Dimension
2012-08-07Siemens Healthcare Diagnostics, IncADVIA Centaur Prolactin Assay and FSH, Calibrator B fails the analytical sensitivity stated in the IFU for lots below 40
2009-08-03Beckman Coulter Inc.The recall was initiated because Beckman Coulter has confirmed that the Active Prolactin ElLISA kit, lot number 890291 over estimates the expected dose values for patient serum sam

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.